Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, Schubert S, Wagenlehner F, Mezei T, Pilatz A, et al: EAU Guidelines on Urological Infections. EAU Guidelines Office, Arnhem, pp13, 2020.

Thompson A, Adamson A, Bahl A, Borwell J, Dodds D, Heath C, Huddart R, McMenemin R, Patel P, Peters J and Payne H: Guidelines for the diagnosis, prevention and management of chemical- and radiation-induced cystitis. J Clin Urol. 7:25–35. 2014.

Frassetto LA, Breyer BN, Kim ED, Goluboff ET, Leslie SW, Sant GR and Talavera F: Nonbacterial and noninfectious cystitis. Available from: https://emedicine.medscape.com/article/2056602-overview. Accessed May 30 2020.

Haldar S, Dru C and Bhowmick NA: Mechanisms of hemorrhagic cystitis. Am J Clin Exp Urol. 2:199–208. 2014.PubMed/NCBI

Mukhtar S and Woodhouse C: The management of cyclophosphamide-induced haematuria. BJU Int. 105:908–912. 2010.PubMed/NCBI View Article : Google Scholar

Korkmaz A, Topal T and Oter S: Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol. 23:303–312. 2007.PubMed/NCBI View Article : Google Scholar

Crawford ML, Waller PC and Wood SM: Severe cystitis associated with tiaprofenic acid. Br J Urol. 79:578–584. 1997.PubMed/NCBI View Article : Google Scholar

Addiction Center: Ketamine addiction and abuse. Available from: https://www.addictioncenter.com/drugs/hallucinogens/ketamine/. Accessed May 30, 2020.

Manikandan R, Kumar S and Dorairajan LN: Hemorrhagic cystitis: A challenge to the urologist. Indian J Urol. 26:159–166. 2010.PubMed/NCBI View Article : Google Scholar

Choong SK, Walkden M and Kirby R: The management of intractable haematuria. BJU Int. 86:951–959. 2000.PubMed/NCBI View Article : Google Scholar

Emadi A, Jones RJ and Brodsky RA: Cyclophosphamide and cancer: Golden anniversary. Nat Rev Clin Oncol. 6:638–647. 2009.PubMed/NCBI View Article : Google Scholar

Lamm D, Persad R, Colombel M and Brausi M: Maintenance bacillus Calmette-Guérin: The standard of care for the prophylaxis and management of intermediate- and high-risk non-muscle-invasive bladder cancer. Eur Urol Suppl. 9:715–734. 2010.

Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, Wolf JS Jr and Schellhammer PF: Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 178:2314–2330. 2007.PubMed/NCBI View Article : Google Scholar

Buchbinder R, Forbes A, Kobben F, Boyd I, Snow RM and McNeil JJ: Clinical features of tiaprofenic acid (surgam) associated cystitis and a study of risk factors for its development. J Clin Epidemiol. 53:1013–1019. 2000.PubMed/NCBI View Article : Google Scholar

Folland DS, Kimbrough RD, Cline RE, Swiggart RC and Schaffner W: Acute hemorrhagic cystitis: Industrial exposure to the pesticide chlordimeform. JAMA. 239:1052–1055. 1978.PubMed/NCBI View Article : Google Scholar

National Cancer Institute: Cancer stat facts: Bladder cancer. Available from: www.seer.cancer.gov/statfacts/html/urinb.html. Accessed May 30, 2020.

Lee YK, Jhang JF and Kuo HC: Clinical outcome of augmentation enterocystoplasty for patients with ketamine-induced cystitis. Pain Physician. 20:E431–E436. 2017.PubMed/NCBI

Martin-Suarez I, D'Cruz D, Mansoor M, Fernandes AP, Khamashta MA and Hughes GR: Immunosuppressive treatment in severe connective tissue diseases: Effects of low dose intravenous cyclophosphamide. Ann Rheum Dis. 56:481–487. 1997.PubMed/NCBI View Article : Google Scholar

Kawabe Y, Eguchi K, Tsuboi M, Kita M, Tsukada T, Takashima H, Mizokami A, Kawakami A, Matsuoka N, Migita K and Nagataki S: Untoward effects of low dose methotrexate therapy in rheumatoid arthritis. Ryumachi. 36:514–521. 1996.PubMed/NCBI(In Japanese).

Juszczak K, Kaszuba-Zwoińska J, Chorobik P, Ziomber A and Thor PJ: The effect of hyperosmolar stimuli and cyclophosphamide on the culture of normal rat urothelial cells in vitro. Cell Mol Biol Lett. 17:196–205. 2012.PubMed/NCBI View Article : Google Scholar

Zupancic D, Jezernik K and Vidmar G: Effect of melatonin on apoptosis, proliferation and differentiation of urothelial cells after cyclophosphamide treatment. J Pineal Res. 44:299–306. 2008.PubMed/NCBI View Article : Google Scholar

Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J and Rouprêt M: European Association of Urology (EAU). EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol. 59:997–1008. 2011.PubMed/NCBI View Article : Google Scholar

Brausi M, Witjes JA, Lamm D, Persad R, Palou J, Colombel M, Buckley R, Soloway M, Akaza H and Böhle A: A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the international bladder cancer group. J Urol. 186:2158–2167. 2011.PubMed/NCBI View Article : Google Scholar

Bassi PF, Costantini E, Foley S and Palea S: Glycosaminoglycan therapy for bladder diseases: Emerging new treatments. Eur Urol Suppl. 10:451–459. 2011.

Lazzeri M and Montorsi F: The therapeutic challenge of ‘chronic cystitis’: Search well, work together, and gain results. Eur Urol. 60:78–80. 2011.PubMed/NCBI View Article : Google Scholar

Brausi M, Oddens J, Sylvester R, Bono A, van de Beek C, van Andel G, Gontero P, Turkeri L, Marreaud S, Collette S and Oosterlinck W: Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: Results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol. 65:69–76. 2014.PubMed/NCBI View Article : Google Scholar

Mitomycin Side Effects. Available from: https://www.drugs.com/sfx/mitomycin-side-effects.html. Accessed May 30, 2020.

Filson CP, Montgomery JS, Dailey SM, Crossley HS, Lentz H, Tallman CT, He C and Weizer AZ: Complications associated with single-dose, perioperative mitomycin-C for patients undergoing bladder tumor resection. Urol Oncol. 32:40.e1–e8. 2014.PubMed/NCBI View Article : Google Scholar

Solsona E, Iborra I, Ricós JV, Monrós JL, Casanova J and Dumont R: Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: Short and long-term followup. J Urol. 161:1120–1123. 1999.PubMed/NCBI

Jansen KL: A review of the nonmedical use of ketamine: Use, users and consequences. J Psychoactive Drugs. 32:419–433. 2000.PubMed/NCBI View Article : Google Scholar

Shahani R, Streutker C, Dickson B and Stewart RJ: Ketamine- associated ulcerative cystitis: A new clinical entity. Urology. 69:810–812. 2007.PubMed/NCBI View Article : Google Scholar

Meng E, Wu ST, Cha TL, Sun GH, Yu DS and Chang SY: A murderer of young bladders: Ketamine-associated cystitis. Urol Sci. 24:113–116. 2013.

Chen WC, Lee MH, Lee SP, Chen YL, Wu HC, Lin HM and Liou WB: The patients with ketamine-induced cystitis (KIC) have more severe lower urinary tract symptoms and smaller bladder capacity than patients with interstitial cystitis/bladder painful syndrome (IC/BPS). Neurourol Urodyn. 31:1005–1006. 2012.

Kim SJ, Koh DH, Park JS, Ahn HS, Choi JB and Kim YS: Hemorrhagic cystitis due to intravesical instillation of gentian violet completely recovered with conservative therapy. Yonsei Med J. 44:163–165. 2003.PubMed/NCBI View Article : Google Scholar

Magee P: Antiseptic drugs and disinfectants. In: Side Effects of Drugs Annual. 1st edition. Vol 23. Aronson JK (ed). Elsevier Science, Amsterrntam, pp247-249, 2000.

Petca RC, Mareș C, Petca A, Negoiță S, Popescu RI, Boț M, Barabás E and Chibelean CB: Spectrum and antibiotic resistance of uropathogens in Romanian females. Antibiotics (Basel). 9(472)2020.PubMed/NCBI View Article : Google Scholar

Trotman J, Nivison-Smith I and Dodds A: Haemorrhagic cystitis: Incidence and risk factors in a transplant population using hyperhydration. Bone Marrow Transplant. 23:797–801. 1999.PubMed/NCBI View Article : Google Scholar

Droller MJ, Saral R and Santos G: Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology. 20:256–258. 1982.PubMed/NCBI View Article : Google Scholar

Jepson RG, Williams G and Craig JC: Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 10(CD001321)2012.PubMed/NCBI View Article : Google Scholar

Das S: Natural therapeutics for urinary tract infections-a review. Futur J Pharm Sci. 6(64)2020.PubMed/NCBI View Article : Google Scholar

Sihra N, Goodman A, Zakri R, Sahai A and Malde S: Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol. 15:750–776. 2018.PubMed/NCBI View Article : Google Scholar

Cowan CC, Hutchison C, Cole T, Barry SJ, Paul J, Reed NS and Russell JM: A randomised double-blind placebo-controlled trial to determine the effect of cranberry juice on decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing radiotherapy for cancer of the bladder or cervix. Clin Oncol (R Coll Radiol). 24:e31–e38. 2012.PubMed/NCBI View Article : Google Scholar

Campbell G, Pickles T and D'yachkova Y: A randomised trial of cranberry versus apple juice in the management of urinary symptoms during external beam radiation therapy for prostate cancer. Clin Oncol (R Coll Radiol). 15:322–328. 2003.PubMed/NCBI View Article : Google Scholar

Hamilton K, Bennett NC, Purdie G and Herst PM: Standardized cranberry capsules for radiation cystitis in prostate cancer patients in New Zealand: A randomized double blinded, placebo controlled pilot study. Support Care Cancer. 23:95–102. 2015.PubMed/NCBI View Article : Google Scholar

Herst PM, Aumata A, Sword V, Jones R, Purdie G and Costello S: Cranberry capsules are not superior to placebo capsules in managing acute non-haemorrhagic radiation cystitis in prostate cancer patients: A phase III double blinded randomised placebo controlled clinical trial. Radiother Oncol. 149:117–123. 2020.PubMed/NCBI View Article : Google Scholar

Turkeri LN, Lum LG, Uberti JP, Abella E, Momin F, Karanes C, Sensenbrenner LL and Haas GP: Prevention of hemorrhagic cystitis following allogeneic bone marrow transplant preparative regimens with cyclophosphamide and busulfan: Role of continuous bladder irrigation. J Urol. 153:637–640. 1995.PubMed/NCBI View Article : Google Scholar

Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, et al: American society of clinical oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants. J Clin Oncol. 27:127–145. 2009.PubMed/NCBI View Article : Google Scholar

Ballen KK, Becker P, Levebvre K, Emmons R, Lee K, Levy W, Stewart FM, Quesenberry P and Lowry P: Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients. Oncology. 57:287–292. 1999.PubMed/NCBI View Article : Google Scholar

Vose JM, Reed EC, Pippert GC, Anderson JR, Bierman PJ, Kessinger A, Spinolo J and Armitage JO: Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: A randomized trial. J Clin Oncol. 11:1306–1310. 1993.PubMed/NCBI View Article : Google Scholar

Tiglis M, Neagu TP, Elfara M, Diaconu CC, Bratu OG, Vacaroiu IA and Grintescu IM: Nefopam and its role in modulating acute and chronic pain. Rev Chim (Bucharest). 69:2877–2880. 2018.

Petca RC, Popescu RI, Mehedintu C, Bot M, Veduta A and Petca A: The role of ultrasound in diagnosis and management in renal colic during . In: Proceedings of the 6th Congress of the Ultrasound Society in Obstetrics and Gynecology/34th Fetus as a Patient International Congress. Bucharest, pp478-484, 2018.

Diaconu CC: Midaortic syndrome in a young man: Case presentation. Cor Vasa. 59:e171–e173. 2017.

Moharamzadeh P, Ojaghihaghighi S, Amjadi M, Rahmani F and Farjamnia A: Effect of tranexamic acid on gross hematuria: A pilot randomized clinical trial study. Am J Emerg Med. 35:1922–1925. 2017.PubMed/NCBI View Article : Google Scholar

Decker DB, Karam JA and Wilcox DT: Pediatric hemorrhagic cystitis. J Pediatr Urol. 5:254–264. 2009.PubMed/NCBI View Article : Google Scholar

Westerman ME, Boorjian SA and Linder BJ: Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: A contemporary evaluation. Int Braz J Urol. 42:1144–1149. 2016.PubMed/NCBI View Article : Google Scholar

Ho CC and Md Zainuddin Z: Alum irrigation for the treatment of intractable haematuria. Malays J Med Sci. 16:66–68. 2009.PubMed/NCBI

Dewan AK, Mohan GM and Ravi R: Intravesical formalin for hemorrhagic cystitis following irradiation of cancer of the cervix. Int J Gynaecol Obstet. 42:131–135. 1993.PubMed/NCBI View Article : Google Scholar

Vicente J, Rios G and Caffaratti J: Intravesical formalin for the treatment of massive hemorrhagic cystitis: Retrospective review of 25 cases. Eur Urol. 18:204–206. 1990.PubMed/NCBI View Article : Google Scholar

Ricciotti E and FitzGerald GA: Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 31:986–1000. 2011.PubMed/NCBI View Article : Google Scholar

Demir HA, Savaş Şen Z, Altuğ MU, Emir S and Tunç B: Successful treatment of cyclophosphamide-induced haemorrhagic cystitis with intravesical prostaglandin E1 in a child with non-Hodgkin's lymphoma. Scand J Urol Nephrol. 45:281–284. 2011.PubMed/NCBI View Article : Google Scholar

Yamamoto M, Hibi H, Ohmura M and Miyake K: Successful treatment of hemorrhagic cystitis secondary to cyclophosphamide chemotherapy with intravesical instillation of prostaglandin F2 alpha. Hinyokika Kiyo. 40:833–835. 1994.PubMed/NCBI

Ippoliti C, Przepiorka D, Mehra R, Neumann J, Wood J, Claxton D, Gajewski J, Khouri I, van Besien K, Andersson B, et al: Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology. 46:811–815. 1995.PubMed/NCBI View Article : Google Scholar

Sommariva ML, Sandri SD and Ceriani V: Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis. Minerva Urol Nefrol. 62:145–150. 2010.PubMed/NCBI

Imperatore V, Creta M, Di Meo S, Buonopane R, Longo N, Fusco F, Spirito L, Imbimbo C and Mirone V: Intravesical administration of combined hyaluronic acid and chondroitin sulfate can improve symptoms in patients with refractory bacillus Calmette-Guerin-induced chemical cystitis: Preliminary experience with one-year follow-up. Arch Ital Urol Androl. 90:11–14. 2018.PubMed/NCBI View Article : Google Scholar

Davis M, MacDonald H, Sames C and Nand K: Severe cyclophosphamide-induced haemorrhagic cystitis treated with hyperbaric oxygen. N Z Med J. 124:48–54. 2011.PubMed/NCBI

Ajith Kumar S, Prasanth P, Tripathi K and Ghosh P: Hyperbaric oxygen-a new horizon in treating cyclophosphamide-induced hemorrhagic cystitis. Indian J Urol. 27:272–273. 2011.PubMed/NCBI View Article : Google Scholar

Duthie G, Whyte L, Chandran H, Lawson S, Velangi M and McCarthy L: Introduction of sodium pentosan polysulfate and avoidance of urethral catheterisation: Improved outcomes in children with haemorrhagic cystitis post stem cell transplant/chemotherapy. J Pediatr Surg. 47:375–379. 2012.PubMed/NCBI View Article : Google Scholar

Abt D, Bywater M, Engeler DS and Schmid HP: Therapeutic options for intractable hematuria in advanced bladder cancer. Int J Urol. 20:651–660. 2013.PubMed/NCBI View Article : Google Scholar

Stefanini M, English HA and Taylor AE: Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract. J Urol. 143:559–561. 1990.PubMed/NCBI View Article : Google Scholar

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH and Elmore JM: Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. J Urol. 184:1152–1157. 2010.PubMed/NCBI View Article : Google Scholar

Liu YK, Harty JI, Steinbock GS, Holt HA Jr, Goldstein DH and Amin M: Treatment of radiation or cyclophosphamide induced hemorrhagic cystitis using conjugated estrogen. J Urol. 144:41–43. 1990.PubMed/NCBI View Article : Google Scholar

Miller J, Burfield GD and Moretti KL: Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol. 151:1348–1350. 1994.PubMed/NCBI View Article : Google Scholar

Ordemann R, Naumann R, Geissler G, Bornhauser M, Schuler U and Ehninger G: Encouraging results in the treatment of haemorrhagic cystitis with estrogen-report of 10 cases and review of the literature. Bone Marrow Transplant. 25:981–985. 2000.PubMed/NCBI View Article : Google Scholar

Mousavi SA, Moazed V, Mohebbi N, Hadjibabaie M, Alimoghaddam K, Bahar B, Jahani M and Ghavamzadeh A: Conjugated estrogen in late-onset hemorrhagic cystitis associated with hematopoietic stem cell transplantation. Int J Hematol Oncol Stem Cell Res. 11:13–18. 2017.PubMed/NCBI

Geisler JP, Linnemeier GC and Manahan KJ: Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: A case report. J Reprod Med. 53:360–362. 2008.PubMed/NCBI

Ashrani AA, Gabriel DA, Gajewski JL, Jacobs DR Jr, Weisdorf DJ and Key NS: Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy. Bone Marrow Transplant. 38:825–828. 2006.PubMed/NCBI View Article : Google Scholar

Karimi M, Zakerinia M, Khojasteh HN, Ramzi M and Ahmad E: Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation. J Thromb Haemost. 2:1853–1855. 2004.PubMed/NCBI View Article : Google Scholar

Pihusch M, Bacigalupo A, Szer J, von Depka Prondzinski M, Gaspar-Blaudschun B, Hyveled L and Brenner B: F7BMT-1360 Trial Investigators. Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation. J Thromb Haemost. 3:1935–1944. 2005.PubMed/NCBI View Article : Google Scholar

Lai HH, Shen B, Vijairania P, Zhang X, Vogt SK and Gereau RW IV: Anti-vascular endothelial growth factor treatment decreases bladder pain in cyclophosphamide cystitis: A multidisciplinary approach to the study of chronic pelvic pain (MAPP) research network animal model study. BJU Int. 120:576–583. 2017.PubMed/NCBI View Article : Google Scholar

Tanik S, Zengin K, Albayrak S, Gurel A, Atar M, Sahin S, Tuzcu N, Tuzcu M, Imamoglu MA and Gurdal M: Assessment of therapeutic effect of human choriogonadotropin in a chemical cystitis model. Kaohsiung J Med Sci. 33:229–235. 2017.PubMed/NCBI View Article : Google Scholar

Acar D, Cayan S, Aktaş S, Tek M and Akbay E: The effect of tamoxifen on bladder functions and histology, and the role of estrogen receptor beta in a rat chemical cystitis model. Neurourol Urodyn. 26:309–316. 2007.PubMed/NCBI View Article : Google Scholar

Ozyuvali E, Yildirim ME, Yaman T, Kosem B, Atli O and Cimentepe E: Protective effect of intravesical platelet-rich plasma on cyclophosphamide-induced hemorrhagic cystitis. Clin Invest Med. 39(27514)2016.PubMed/NCBI

Jiang YH, Liao CH and Kuo HC: Current and potential urological applications of botulinum toxin A. Nat Rev Urol. 12:519–533. 2015.PubMed/NCBI View Article : Google Scholar

Chibelean CB, Nechifor-Boilă IA, Petca RC, Balan D, Martha O, Petca A and Dogaroiu C: Abobotulinumtoxin A in idiopathic hyperactive bladder-ethical issues. Rom J Leg Med. 27:213–216. 2019.

Chuang YC, Kim DK, Chiang PH and Chancellor MB: Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis. BJU Int. 102:704–706. 2008.PubMed/NCBI View Article : Google Scholar